Molecular pharmacology and structure of VPAC Recep...[Regul Pept. 2002]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Regul Pept. 2002 Oct 15;108(2-3):165-73. Links

Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.

Laburthe M, Couvineau A.

Neuroendocrinology and Cell Biology, INSERM U41O, Faculté de Médecine Xavier Bichat, 75018, Paris, France. laburhe@bichat.inserm.fr

VIP and PACAP are two prominent neuropeptides which share two common G protein-coupled receptors VPAC1 and VPAC2 while PACAP has an additional specific receptor PAC1. This paper reviews the present knowledge regarding three aspects of VPAC receptors including: (i). receptor specificity towards natural VIP-related peptides and pharmacology of synthetic agonists or antagonists; (ii). receptor signaling; (iii). molecular basis of ligand-receptor interaction as determined by site-directed mutagenesis, construction of receptor chimeras and structural modeling.

PMID: 12220741 [PubMed - indexed for MEDLINE]

A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Endocrinology. 1999 Mar; 140(3):1285-93.

[Endocrinology. 1999]
ReviewVPAC receptors for VIP and PACAP.
Receptors Channels. 2002; 8(3-4):137-53.

[Receptors Channels. 2002]
Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Int J Mol Med. 2002 Mar; 9(3):233-43.

[Int J Mol Med. 2002]
Review[Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system]
Yakugaku Zasshi. 2002 Dec; 122(12):1109-21.

[Yakugaku Zasshi. 2002]
Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Endocrinology. 2002 Apr; 143(4):1253-9.

[Endocrinology. 2002]
» See reviews... | » See all...

Cited by 9 PubMed Central articles

PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery.
Yang Y, Shi Y, Guo S, Zhang S, Cui N, Shi W, Zhu D, Jiang C. Biochim Biophys Acta. 2008 Jan; 1778(1):88-96. Epub 2007 Sep 12.

[Biochim Biophys Acta. 2008]
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation.
Zhang K, Aruva MR, Shanthly N, Cardi CA, Patel CA, Rattan S, Cesarone G, Wickstrom E, Thakur ML. Regul Pept. 2007 Dec 4; 144(1-3):91-100. Epub 2007 Jul 6.

[Regul Pept. 2007]
Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
Vanneste G, Dhaese I, Sips P, Buys E, Brouckaert P, Lefebvre RA. J Physiol. 2007 Nov 1; 584(Pt 3):907-20. Epub 2007 Aug 23.

[J Physiol. 2007]
» See all...

Recent Activity

Clear Turn Off Turn On

Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.

Related articles

Cited by 9 PubMed Central articles

Recent Activity